Introduction to Cephalosporin Drugs
Cephalosporin drugs are a type of anti-microbial drugs used to kill a large variety of bacteria. These semi-synthetic antibiotics, derived from fungal molds, are used to treat a diverse range of bacterial infections such as skin and ear infections, urinary tract infections etc. These drugs are constantly becoming advanced both in structure and function in order to compete with the rise in drug resistance property of bacterial strains.
The course of action of cephalosporin drugs involves their interference with the synthesis of bacterial cell walls, causing an obstruction in the multiplication process of bacteria in the host body. Since bacteria have a limited lifespan and are not able to further divide, they eventually die and the infection is treated.
Cephalosporin drugs are also known as broad spectrum antibiotics due to their ability to affect a wide range of bacteria including both gram-positive and gram-negative bacteria. The gram-negative bacteria are difficult to treat since their cell wall is hard to destroy, but the development of fifth generation cephalosporin drugs has made it possible to treat even the severe infections caused by such bacteria. In addition, these drugs can be prescribed to patients as an alternative to Penicillin.
Market Size and Forecast
The growing market size of cephalosporin drugs can be attributed to an upsurge in the rate of evolution of multi-drug resistant strains of bacteria all over the world. This has driven the research and development activities pertaining to cephalosporin drugs as a part of combination therapy. The production of cephalosporin drugs has seen a sudden incline on account of a high demand for these drugs, especially in the third world countries. Owing to these factors, the market size of the cephalosporin drugs market is estimated to reach a significantly high value by 2027.
The global cephalosporin drugs market is anticipated to record a CAGR of around 3% over the forecast period, i.e., 2019-2027. The market is segmented by generation into first-generation, second-generation, third-generation, fourth-generation and fifth-generation, out of which, the fifth-generation drugs segment is anticipated to lead the global cephalosporin drugs market share on account of high demand for combination therapies for the treatment of bacterial infections. The fifth generation of these drugs comprises of a combination of two or more drugs which intensify the effect of the drug on the bacteria. Therefore, the market for cephalosporin drugs is anticipated to grow on the back of rising incidences of bacterial infections and high effectiveness of these drugs.
Get more information on this report: Download Sample PDF
Growth Drivers
Increasing Expenditure on Healthcare
The growing population and declining hygienic conditions, especially in regions such as Asia, have made it a breeding ground for all kinds of bacteria, leading to a high prevalence of infectious diseases. To avoid this, many countries have increased their expenditure on development of the healthcare industry by spending more on several clinical studies. This is likely to provide a lot of opportunities for the new and existing companies operating in the cephalosporin drugs market.
High Efficacy of Combinational Therapies
Drugs are being used in various combinations in order to increase the effectiveness on bacteria in the form of combinational therapies. These have proved to be much more effective for treatment of infections than using a single drug. For instance, fifth generation cephalosporin is one such example of combinational therapy drugs which exhibit activity against Methicillin-Resistant Staphylococcus Aureus (MRSA) bacteria.
Increasing Awareness Among People
As bacterial infections are becoming increasingly common, people are getting more aware of the ill-effects of diseases caused by them. Additionally, this is also leading to an increase in the availability of multiple treatment options for the diseases as well as improvement in the composition of these drugs.
Restraints
Allergic Reactions Similar to Penicillin
Some clinical studies have found that cephalosporin drugs, which are made from the fungus Cephalosporin, show allergic effects similar to another fungal drug Penicillin. Therefore, people experiencing allergic reactions might restrict the growth of the market over the forecast period.
Strict Government Policies
Some regions have imposed strict government policies against the production of cephalosporin drugs, which might hinder the growth of the market in that particular region instead of affecting the overall growth globally.
Market Segmentation
Our in-depth analysis of the global cephalosporin drugs market includes the following segments:
By Generation
- First-Generation
- Second-Generation
- Third-Generation
- Fourth-Generation
- Fifth-Generation
By Drug Administration Route
- Oral
- Injection
By Drug Type
- Branded
- Generics
By Application
- Skin Infections
- Ear Infections
- Urinary Tract Infections
- Respiratory Tract Infections
- Sexually Transmitted Infections
- Others
By Region
On the basis of regional analysis, the global cephalosporin drugs market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.
The region with the highest anticipated growth of the global cephalosporin drugs market is the Asia-Pacific. It has the fastest growing market owing to factors such as a high occurrence of bacterial infections in this area, increasing measures to expand the research and development on healthcare along with the presence of huge population which is expanding at a faster rate. The growing emphasis on production of safe-to-consume drugs plays an important role behind the growth of the market in this region.
The global cephalosporin drugs market is further classified on the basis of region as follows:
- North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
- Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis
Top Featured Companies Dominating the Market
- Astellas
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Lupin Pharmaceuticals
- Glaxo SmithKline
- Merck & Co.
- Pfizer
- Sandoz
- Teva Pharmaceuticals
- Baxtor International
- Macleods Pharmaceuticals Ltd.
- F. Hoffmann-La Roche AG
